mailed
on 28 Feb 2024
Last Applicant/ Owned by
EPFL Innovation Park
Lausanne
CH
CH-1015
Serial Number
88636116 filed on 30th Sep 2019
Registration Number
N/A
Correspondent Address
Kristina Montanaro Schrader
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"IMMUNE"
Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biologicalRead More
Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; biological research, namely, screening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and development, namely, vaccine and antibody engineering
Pharmaceuticals, medical and veterinary preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds, all for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodies, antibody fragments and antibody derivatives for use in disease testing, diagnosis, prevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes
Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements, namely, chemical preparations for industrial and scientific purposes, other than for medical or veterinary use; chemical, biochemical, biological and biotechnological preparations for use in industry and science; protein, protein fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular libraries, comprising libraries of chemical preparations for use in industry and science; small molecule library, comprising libraries of chemical preparations for use in industry and science; antibody library, comprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparations, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use
No 88636116
No Service Mark
No AC Immune
Yes
No
No
Yes
No
No
No
No
26.01.13 -
Two circles
26.01.16 -
Circles touching or intersecting
26.01.21 -
Circles that are totally or partially shaded
The mark consists of two interlocking circles to the left of the text "AC IMMUNE". One circle is yellow and the other circle is red. Where the circles interlock, they are orange. The outer edges of the circles are thinner than the inner portions of the circles. The colour white represents background, outlining, shading and/or transparent area and is not part of the mark. The colour black represents outlining and/or shading and is not claimed as a feature of the mark.
| Status Date | Action Taken |
|---|---|
| 28th Feb 2024 | SUSPENSION INQUIRY WRITTEN |
| 28th Feb 2024 | INQUIRY TO SUSPENSION E-MAILED |
| 28th Feb 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 06th Dec 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| 04th Dec 2023 | ASSIGNED TO EXAMINER |
| 30th Nov 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| 27th Apr 2022 | SUSPENSION LETTER WRITTEN |
| 27th Apr 2022 | LETTER OF SUSPENSION E-MAILED |
| 27th Apr 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 14th Feb 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
